Uploaded August 2026 | Updated September 2026, 3 weeks ago
Representative Debbie Dingell (D-MI) asks Thomas J. Bollyky, director of CFR’s Global Health program, if funding cuts to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) are causing researchers to leave the United States for more stable funding environments. “We are already seeing a flow of scientists out of the U.S. That’s a product of the difficulty of the U.S. funding environment, as well as the rise or emergence of China’s biopharmaceutical industry,” Bollyky states.
Subscribe to our channel: goo.gl/WCYsH7
This work represents the views and opinions solely of the author. The Council on Foreign Relations is an independent, nonpartisan membership organization, think tank, and publisher, and takes no institutional positions on matters of policy.
Visit the CFR website: cfr.org
Follow CFR on X: twitter.com/cfr_org
Follow CFR on Facebook: facebook.com/councilonforeignrelations
Representative Debbie Dingell (D-MI) asks Thomas J. Bollyky, director of CFR’s Global Health program, if funding cuts to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) are causing researchers to leave the United States for more stable funding environments. “We are already seeing a flow of scientists out of the U.S. That’s a product of the difficulty of the U.S. funding environment, as well as the rise or emergence of China’s biopharmaceutical industry,” Bollyky states.
Subscribe to our channel: goo.gl/WCYsH7
This work represents the views and opinions solely of the author. The Council on Foreign Relations is an independent, nonpartisan membership organization, think tank, and publisher, and takes no institutional positions on matters of policy.
Visit the CFR website: cfr.org
Follow CFR on X: twitter.com/cfr_org
Follow CFR on Facebook: facebook.com/councilonforeignrelations
